← All organizations

Regenxbio Inc.

For profitWebsite ↗

Also known as: Regenxbio Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 25, 2025

Timeline

2000s

Jun 1, 2009
Regenxbio Inc.— Founded

Drugs by trial phase (7 distinct, 13 trials)

Phase 3 (4 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

rgx-111

Indications

Studied for

Recent trials (13)

NCT07236606Lead sponsorPhase 3Nov 25, 2025
NCT06942520CollaboratorPhase 2Mar 18, 2025
NCT05791864Lead sponsorPhase 1/Phase 2May 17, 2023
NCT05693142Lead sponsorPhase 1/Phase 2Jan 4, 2023
NCT05407636Lead sponsorPhase 3Dec 28, 2021
NCT04832724Lead sponsorPhase 2Feb 22, 2021
NCT04704921Lead sponsorPhase 2/Phase 3Dec 29, 2020
NCT04571970Lead sponsorPhase 1/Phase 2Nov 30, 2020
NCT04567550Lead sponsorPhase 2Nov 20, 2020
NCT04514653Lead sponsorPhase 2Aug 13, 2020
NCT03580083Lead sponsorPhase 1Sep 30, 2018
NCT03566043Lead sponsorPhase 1/Phase 2Jul 31, 2018
NCT03066258Lead sponsorPhase 1Mar 31, 2017

Details

Founded: Rockville, MD, US Jun 1, 2009
Last known activity: Nov 25, 2025